These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6141773)

  • 1. U-43,465F: a triazolobenzodiazepine with pronounced antidepressant-like as well as anxiolytic activities in animals.
    Von Voigtlander PF; Puech AJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):60-76. PubMed ID: 6141773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. U 43,465F: a benzodiazepine with antidepressant activity? Interaction with Ro 15-1788 and d,1-propranolol.
    Thiebot MH; Doare L; Puech AJ; Simon P
    Eur J Pharmacol; 1982 Oct; 84(1-2):103-6. PubMed ID: 6128234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine.
    Lahti RA; Sethy VH; Barsuhn C; Hester JB
    Neuropharmacology; 1983 Nov; 22(11):1277-82. PubMed ID: 6320036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurochemical and behavioral study on the mechanism of the antidepressant and anxiolytic effect of co-administration of lithium and monoamine oxidase inhibitors].
    Kitaichi Y
    Hokkaido Igaku Zasshi; 2004 Jan; 79(1):93-101. PubMed ID: 14978979
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.
    Owens MJ; Bissette G; Nemeroff CB
    Synapse; 1989; 4(3):196-202. PubMed ID: 2575286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adinazolam affects biogenic amine release in hippocampal CA1 neuronal circuitry.
    Broderick PA
    Brain Res Bull; 1991 Nov; 27(5):689-92. PubMed ID: 1756387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 3,4-dihydro-lH-1,4-oxazino[4,3-a] indoles, potential antidepressants, on biogenic amine uptake mechanisms and related activities.
    Lippmann W; Pugsley TA
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):324-42. PubMed ID: 303083
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies on antidepressant action of alprazolam in different animal models.
    Kostowski W; Malatyńska E; Płaźnik A; Dyr W; Danysz W
    Pol J Pharmacol Pharm; 1986; 38(5-6):471-81. PubMed ID: 2883637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
    Biała G
    Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
    Shobo M; Kondo Y; Yamada H; Mihara T; Yamamoto N; Katsuoka M; Harada K; Ni K; Matsuoka N
    J Pharmacol Exp Ther; 2010 Jun; 333(3):772-81. PubMed ID: 20223878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological characterization and mechanisms of the novel antidepressive- and/or anxiolytic-like substances identified from Perillae Herba].
    Tsuji M; Miyagawa K; Takeuchi T; Takeda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Aug; 28(4):159-67. PubMed ID: 18800619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor.
    Chaki S; Hirota S; Funakoshi T; Suzuki Y; Suetake S; Okubo T; Ishii T; Nakazato A; Okuyama S
    J Pharmacol Exp Ther; 2003 Feb; 304(2):818-26. PubMed ID: 12538838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant- and anxiolytic-like activity of magnesium in mice.
    Poleszak E; Szewczyk B; Kedzierska E; Wlaź P; Pilc A; Nowak G
    Pharmacol Biochem Behav; 2004 May; 78(1):7-12. PubMed ID: 15159129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
    Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
    Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.